Cancer treatment disparities in HIV-infected individuals in the United States.

Elevated Cancer-Specific Mortality Among HIV-Infected Patients in the United States. J Clin Oncol (2015) 2.40

Survival among HIV-infected and HIV-uninfected individuals with common non-AIDS-defining cancers. Cancer Epidemiol Biomarkers Prev (2015) 0.92

Lentivirus-mediated Gene Transfer in Hematopoietic Stem Cells Is Impaired in SHIV-infected, ART-treated Nonhuman Primates. Mol Ther (2015) 0.82

Cancer stage at diagnosis in patients infected with the human immunodeficiency virus and transplant recipients. Cancer (2015) 0.80

Retrospective cohort study of cancer incidence and mortality by HIV status in a Georgia, USA, prisoner cohort during the HAART era. BMJ Open (2016) 0.77

Cancer prevention in HIV-infected populations. Semin Oncol (2015) 0.77

Outcomes of abdominoperineal resection for management of anal cancer in HIV-positive patients: a national case review. World J Surg Oncol (2016) 0.75

HIV-associated hematologic malignancies: Experience from a Tertiary Cancer Center in India. Indian J Med Paediatr Oncol (2016) 0.75

Lung cancer in persons with HIV. Curr Opin HIV AIDS (2017) 0.75

High-Risk HPV, Biomarkers, and Outcome in Matched Cohorts of Head and Neck Cancer Patients Positive and Negative for HIV. Mol Cancer Res (2016) 0.75

Risk of Cancer among Commercially Insured HIV-Infected Adults on Antiretroviral Therapy. J Cancer Epidemiol (2016) 0.75

Are cancer outcomes worse in the presence of HIV infection? Cancer Epidemiol Biomarkers Prev (2015) 0.75

Deaths Due to Screenable Cancers Among People Living With HIV Infection, Florida, 2000-2014. Am J Prev Med (2017) 0.75

Risk Of Colorectal Cancer And Associated Mortality In Hiv: A Systematic Review And Meta-Analysis. J Acquir Immune Defic Syndr (2017) 0.75

Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med (2008) 7.71

Association of cancer with AIDS-related immunosuppression in adults. JAMA (2001) 6.80

Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst (2005) 6.69

Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA (1998) 6.69

Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst (2002) 6.64

Spectrum of AIDS-associated malignant disorders. Lancet (1998) 5.30

Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol (2003) 4.77

Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst (2011) 4.69

Age at cancer diagnosis among persons with AIDS in the United States. Ann Intern Med (2010) 4.30

A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr (2009) 3.76

Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010. Blood (2005) 3.26

HIV infection and the risk of cancers with and without a known infectious cause. AIDS (2009) 3.13

Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis. AIDS (2002) 1.98

Immune deficiency and risk for malignancy among persons with AIDS. J Acquir Immune Defic Syndr (2003) 1.96

Cancer as a cause of death among people with AIDS in the United States. Clin Infect Dis (2010) 1.78

Survival after cancer diagnosis in persons with AIDS. J Acquir Immune Defic Syndr (2005) 1.71

Delayed diagnosis and elevated mortality in an urban population with HIV and lung cancer: implications for patient care. J Acquir Immune Defic Syndr (2006) 1.66

The rising challenge of non-AIDS-defining cancers in HIV-infected patients. Clin Infect Dis (2012) 1.62

HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era. J Clin Oncol (2012) 1.55

Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy. J Clin Oncol (2001) 1.55

Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998. J Infect Dis (2002) 1.49

Including persons with HIV infection in cancer clinical trials. J Clin Oncol (2008) 1.30

Use of antineoplastic agents in patients with cancer who have HIV/AIDS. Lancet Oncol (2011) 1.30

British HIV Association guidelines for HIV-associated malignancies 2008. HIV Med (2008) 1.23

Mortality due to cancer among people with AIDS: a novel approach using registry-linkage data and population attributable risk methods. AIDS (2012) 1.19

Lung cancer in patients with HIV-infection. Lung Cancer (1996) 1.17

Non-AIDS-Defining Malignancies in Patients with HIV in the HAART Era. Curr Infect Dis Rep (2010) 1.17

Disparities in the treatment and outcomes of lung cancer among HIV-infected individuals. AIDS (2013) 1.16

Lung carcinoma in 36 patients with human immunodeficiency virus infection. The Italian Cooperative Group on AIDS and Tumors. Cancer (2000) 1.13

Treatment of HIV-associated invasive anal cancer with combined chemoradiation. Eur J Cancer (2000) 1.11

Invasive anal squamous-cell carcinoma in the HIV-positive patient: outcome in the era of highly active antiretroviral therapy. Dis Colon Rectum (2007) 1.11

Human immunodeficiency virus and lung cancer. Br J Surg (1997) 1.08

Human immunodeficiency virus-associated adenocarcinoma of the colon: clinicopathologic findings and outcome. Clin Colorectal Cancer (2009) 1.08

Acquired immunodeficiency syndrome-related lymphoma: simultaneous treatment with combined cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy and highly active antiretroviral therapy is safe and improves survival--results of the German Multicenter Trial. Cancer (2006) 1.04

Interactions between antiretrovirals and antineoplastic drug therapy. Clin Pharmacokinet (2005) 1.01

Lung cancer in patients with HIV Infection and review of the literature. Med Oncol (2004) 0.96

Lung cancer in HIV Infection. Clin Lung Cancer (2011) 0.95

Combined modality therapy for HIV-infected patients with squamous cell carcinoma of the anus: outcomes and toxicities. Int J Radiat Oncol Biol Phys (2006) 0.91

Lung cancer in patients with immunodeficiency syndrome. Chest (1993) 0.90

HIV-Associated Hodgkin's Lymphoma: Prognosis and Therapy in the Era of cART. Adv Hematol (2012) 0.88

Chemotherapy consisting of doxorubicin, bleomycin, vinblastine, and dacarbazine with granulocyte-colony-stimulating factor in HIV-infected patients with newly diagnosed Hodgkin's disease: a prospective, multi-institutional AIDS clinical trials group study (ACTG 149). J Acquir Immune Defic Syndr (2000) 0.87

AIDS and non-AIDS-related malignancies: a new vexing challenge in HIV-positive patients. Part II. Cervical and anal squamous epithelial lesions, lung cancer, testicular germ cell cancers, and skin cancers. Eur J Intern Med (2002) 0.81

Low acute toxicity of radiotherapy and radiochemotherapy in patients with cancer of the anal canal and HIV-infection. Acta Oncol (1997) 0.80

Lung cancer in patients with human immunodeficiency virus infection. Am J Clin Oncol (1995) 0.80

Combined antineoplastic and antiretroviral therapy for patients with Hodgkin's disease and human immunodeficiency virus infection. A prospective study of 17 patients. The Italian Cooperative Group on AIDS and Tumors (GICAT). Cancer (1994) 0.79

Oxaliplatin based chemotherapy and concomitant highly active antiretroviral therapy in the treatment of 24 patients with colorectal cancer and HIV infection. Curr HIV Res (2010) 0.78

Management of prostate cancer in HIV-positive patients. Nat Rev Urol (2010) 0.77

Management of HIV-related lymphoma in HIV treatment centres in North Thames Region. Int J STD AIDS (2004) 0.76